Laboratory tests are often very helpful in determining the extent of envenoming,
but this does not mean only a large hospital with a well-equipped laboratory
can manage a snakebite. It is also vital to repeat tests, even if initially
normal. If the patients initial examination and tests are normal, indicating
no current envenoming, the tests should be repeated at about 2 hours and then
a further 3 hours later, to ensure late development of envenoming, particularly
coagulopathy, is not missed. In some situations, particularly some viper bites
causing coagulopathy (notably Malayan pit viper bite), this may persist, develop
late, or recur after antivenom therapy, so retesting over several days may be
required. Earlier testing is indicated if symptoms or signs develop.
A small or rural hospital
Many snakebites will initially present to a small rural hospital with no laboratories
on-site. However, there are some very useful tests that can easily be performed:
Urinalysis looking for haemoglobin/myoglobin (both test positive for blood).
Simple microscopy looking for red cells or casts may help differentiate between
haemoglobinuria and myoglobinuria.
Whole blood clotting time. This simple but effective test requires at least
two standard glass test tubes or similar glass containers. A small quantity
of the patients blood is placed in one tube, a similar amount of blood
from a normal control (relative or staff member) is placed in another tube
and the time taken to clot is measured. If normal, the blood should clot in
5-10 minutes. If the only patients blood fails to clot or develops only
a weak clot by 15 minutes, then there is probably a coagulopathy. If neither
the patient nor control clot then there is a problem with the test system.
It has been suggested that this test can be simplified, by only checking for
clots 20 minutes after taking the sample; a normal clot indicates no coagulopathy,
while a weak clot or no clot indicates coagulopathy.
Only in Australia; snake venom detection on the bite site swab.
In a smaller Australian
country hospital, with no rapid access to a medical laboratory, the following
Whole blood clotting time (perform in a GLASS test tube, simultaneously
with blood from a normal control).
Though untested by clinical trial in snakebite, the recently available d-dimer
test kit for screening for DVT (Simplify D-dimer; AGEN Biomedical Ltd.) may
offer a further useful test for country hospitals. However, its applicability
to snakebite has yet to be confirmed.
If initial tests are normal, repeat 2-3 hours and 5-6 hours later, or earlier
if symptoms of envenoming develop. If initial tests are abnormal and antivenom
therapy is commenced, re-test at 3 hours after completion of antivenom, to decide
if more antivenom is needed (if there is a coagulopathy present).
IMPORTANT INFORMATION FOR ALL SITE USERS
: The principle aim of this site is to provide
information useful to improving outcomes for humans suffering from envenoming or poisoning by
animals, plants or mushrooms. We make a reasonable attempt to verify accuracy of information
listed on this site. However, we cannot access every published paper of potential relevance,
either because they are not available to us or are in a language we cannot translate internally.
Equally, we cannot list knowledge which is not yet reported or known. It should not be assumed
that humankind currently knows all there is to know about any species, even for common species.
Further, we cannot control how users will interpret the information provided on this site. We
therefore do not accept legal responsibility for use of the information provided and we require
that all users use information from this site at their own risk.
The following should also be noted when reading information contained within the databases on this website: italics for scientific nomenclature cannot be displayed, and superscripting and subscripting is absent in some instances.
Photos downloaded from Wikimedia Commons or other website are licensed for use under the Creative Commons Attribution-Share Alike 2.0 Generic license (CC BY-SA 2.0), 2.5 Generic license (CC BY-SA 2.5) or 3.0 Unported license (CC BY-SA 3.0), or the Attribution-NonCommerical-ShareAlike 3.0 Unported license (CC BY-NC-SA 3.0), or the Attribution-Share Alike 4.0 International license (CC BY-SA 4.0), or the GNU General Public License (GPL3.0), or in the Public Domain (PD), as shown in the caption to the image displayed on www.toxinology.com.